ReviewWorld journal of oncology2024

Opportunities and Challenges in the Development of Antibody-Drug Conjugate for Triple-Negative Breast Cancer: The Diverse Choices and Changing Needs.

Qi Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.